Joslin Diabetes Center researchers find bariatric surgery to be more effective at weight control than medical and lifestyle interventions for type 2 diabetes.
Advance SeaStar Medical’s first-in-class SCD therapy for the adult AKI indication - a potential $4.5 billion market - through completion of enrollment of the NEUTRALIZE-AKI pivotal trial and ...
Zacks Small Cap Research on MSN
ICU: Critical care innovation for AKI patients; initiating coverage of SeaStar Medical Holding Corp.
By David Bautz, PhD NASDAQ:ICU READ THE FULL ICU RESEARCH REPORT We are initiating coverage of SeaStar Medical Holding Corp. (NASDAQ:ICU) with a valuation of $12.00. SeaStar is a commercial-stage ...
PainTEQ, a leader in minimally invasive solutions for sacroiliac (SI) joint dysfunction, today announced a significant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results